Urologists 'Outraged' Over PSA Test Challenge
American Urological Association President Sushil S. Lacy, MD, said in prepared remarks that he was "outraged" by the report. "It is inappropriate and irresponsible to issue a blanket statement against PSA testing, particularly for at-risk populations such as African-American men," Lacy said. "Men who are in good health and have more than 10-15 years life expectancy should have the choice to be tested and not discouraged from doing so."
A similar statement was issued this week by the American Association of Clinical Urologists, which called the USPSTF recommendations "misleading and harmful." The major urological associations say the USPSTF ignored new studies supporting the value of PSA tests, and that the panel refused to address concerns they raised about the conclusions during the comment period. In addition, the urologists complain that there were no urologists or oncologists on the panel.
Siegel, who is also the president and CEO of Maryland-based Chesapeake Urology Associates, says urologists have long understood that the PSA test can lead to a high percentage of false positives, but he said that doesn't mean the test should be discounted.
"It is just a screening test, one of several things we look at when we decide whether a man needs a biopsy or not," he says.
- RN Named Chief Patient Experience Officer
- No Employee Satisfaction, No Patient-Centered Culture
- How Simple Data Analytics is Driving Physician Incentives
- AMA Pushes Lame Duck Congress for SGR Repeal
- Medicare to Finally Pay Doctors for Care They Were Giving Away
- Medicare Cost, Quality Data Tools Weak, Says GAO
- Quality in Ambulatory Surgical Settings Gets a Closer Look
- As Retail Clinics Surge, Quality Metrics MIA
- How Payers Are Curbing Behavioral-Health Cost Drivers
- Population Health Pays Off for NY Collaborative